4-(4-chlorophenyl)-3-tosylquinoline | 1093733-89-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 4-(4-chlorophenyl)-3-tosylquinoline
• 英文别名: 4-(4-Chloro-phenyl)-3-(4-methyl-benzenesulfonyl)-quinoline；4-(4-chlorophenyl)-3-(4-methylphenyl)sulfonylquinoline
• CAS: 1093733-89-1
• 化学式: C₂₂H₁₆ClNO₂S
• 分子量: 393.894
• InChiKey: DUFVRRKYTIGEFW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.05
• 拓扑面积：
  55.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(4-chlorophenyl)-3-tosylquinoline 在 盐酸 作用下， 以 乙酸乙酯 为溶剂， 以80%的产率得到4-(4-chlorophenyl)-3-(p-tosyl)quinoline hydrochloride
  参考文献：
  名称：

  Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications

  摘要：

  Negative allosteric modulators (NAM) of metabotropic glutamate receptor 5 (mGluR5) have been implicated as a potential pharmacotherapy for a number of psychiatric diseases, including anxiety and depression. Most of the mGluR5 NAM clinical candidates can be characterized by the central acetylenic moiety that connects the terminal pharmacophores. Identification of a sulfoquinoline hit via high throughput screening (HTS) followed by optimization provided a 4-phenyl-3-aryl-sulfoquinoline lead compound with the minimal pharmacophore. Optimization of the core and aryl appendages was performed by scanning and matrix libraries synthesized by the multiple parallel synthesis approach. Biological evaluation of matrix libraries provided a number of potent, metabolically stable, and in vivo active compounds. One of these compounds, 25 showed high efficacy and safety in preclinical in vivo models; this allowed its nomination as a novel, nonacetylenic mGluR5 NAM clinical candidate. Compound 25 was advanced to first-in-man trials for the treatment of psychiatric conditions.

  DOI：

  10.1021/acs.jmedchem.6b01858
• 作为产物：
  描述：

  3-bromoquinolin-4(1H)-one 在 四(三苯基膦)钯 双氧水 、 potassium carbonate 、 sodium t-butanolate 、 三氯氧磷 作用下， 以 1,4-二氧六环 、 N,N-二甲基甲酰胺 、 三氟乙酸 为溶剂， 反应 36.0h， 生成 4-(4-chlorophenyl)-3-tosylquinoline
  参考文献：
  名称：

  WO2008/155588

  摘要：

  公开号：

文献信息

• Electrooxidative tandem cyclization of <i>N</i>-propargylanilines with sulfinic acids for rapid access to 3-arylsulfonylquinoline derivatives
  作者：Jie Liu、Min Wang、Laiqiang Li、Lei Wang

  DOI：10.1039/d1gc00171j

  日期：——

  A series of N-propargylanilines (0.2 mmol) and sulfinic acids (0.5 mmol) afforded 3-arylsulfonylquinoline derivatives in high yields (70–93%) and low current efficiencies upon electrooxidation. Electrolyses were carried out in a one-compartment cell, under constant current and ambient conditions, in methanol-nBu4NBF4 containing pyridine (0.4 mmol), without any added chemical oxidant. A scale-up electrolysis

  一系列N-炔丙基苯胺（0.2 mmol）和亚磺酸（0.5 mmol）以高收率（70-93％）和低电氧化效率提供了3-芳基磺酰基喹啉衍生物。在恒定电流和环境条件下，在单隔室的电解池中，在不添加任何化学氧化剂的，含有吡啶（0.4 mmol）的甲醇-n Bu 4 NBF 4中进行电解。在5mmol的N-炔丙基苯胺1a上进行放大电解，得到3-芳基磺酰基喹啉3aa，产率为65％，电流效率为56％。提出了机械学假说。
• A visible-light-induced oxidative cyclization of <i>N</i>-propargylanilines with sulfinic acids to 3-sulfonated quinoline derivatives without external photocatalysts
  作者：Yicheng Zhang、Wei Chen、Xueshun Jia、Lei Wang、Pinhua Li

  DOI：10.1039/c8cc10235j

  日期：——

  A visible-light-induced oxidative cyclization of N-propargyl anilines with sulfinic acids was developed under external photocatalyst-free conditions. The reaction provides a straightforward route to 3-sulfonated quinoline derivatives with good functional group tolerance, excellent yields and high regio-selectivity.

  在无外部光催化剂的条件下，可见光诱导了亚磺酸与N-炔丙基苯胺的氧化环化反应。该反应提供了具有良好的官能团耐受性，优异的产率和高的区域选择性的3-磺化喹啉衍生物的直接途径。
• Sulfonyl-Quinoline Derivatives
  申请人：Galambos Janos

  公开号：US20090042934A1

  公开（公告）日：2009-02-12

  The present invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I) and/or salts and/or hydrates and/or solvates and/or polymorphs thereof. The invention also relates to processes and intermediates for their preparation, to pharmaceutical compositions containing these compounds and to their use in treatment and/or prevention of conditions which require modulation of mGluR1 and mGluR5 receptors.

  本发明涉及公式（I）及/或其盐和/或水合物和/或溶剂化物和/或多晶型的新型mGluR1和mGluR5受体亚型偏爱配体。本发明还涉及它们的制备过程和中间体，包含这些化合物的制药组合物以及它们在需要调节mGluR1和mGluR5受体的情况下的治疗和/或预防的用途。
• Sulfonyl-quinoline derivatives
  申请人：Richter Gedeon Nyrt.

  公开号：US08063220B2

  公开（公告）日：2011-11-22

  The present invention relates to new mGluR1 and mGluR5 receptor subtype preferring ligands of formula (I) and/or salts and/or hydrates and/or solvates and/or polymorphs thereof. The invention also relates to processes and intermediates for their preparation, to pharmaceutical compositions containing these compounds and to their use in treatment and/or prevention of conditions which require modulation of mGluR1 and mGluR5 receptors.

  本发明涉及公式（I）的新型mGluR1和mGluR5受体亚型优先配体和/或其盐和/或水合物和/或溶剂化物和/或多晶体。本发明还涉及制备这些化合物的过程和中间体，含有这些化合物的制药组合物以及它们在需要调节mGluR1和mGluR5受体的疾病的治疗和/或预防中的使用。
• SULFONYL-QUINOLINE DERIVATIVES
  申请人：Richter Gedeon Nyrt.

  公开号：EP2167469B1

  公开（公告）日：2012-08-15